BACKGROUND: Stem cell mobilization, which is defined as the forced egress of stem cells from the bone marrow to the peripheral blood (PB) using chemokine receptor agonists, is an emerging concept for enhancing tissue regeneration. However, the effect of stem cell mobilization by a single injection of the C-X-C chemokine receptor type 4 (CXCR4) antagonist AMD3100 on intramembranous bone regeneration is unclear. QUESTIONS/PURPOSES: We therefore asked: Does AMD3100 mobilize adult stem cells in C57BL/6 mice? Are stem cells mobilized to the PB after marrow ablation? And does AMD3100 enhance bone regeneration? METHODS: Female C57BL/6 mice underwent femoral marrow ablation surgery alone (n = 25), systemic injection of AMD3100 alone (n = 15), or surgery plus AMD3100 (n = 57). We used colony-forming unit assays, flow cytometry, and micro-CT to investigate mobilization of mesenchymal stem cells, endothelial progenitor cells, and hematopoietic stem cells to the PB and bone regeneration. RESULTS: AMD3100 induced mobilization of stem cells to the PB, resulting in a 40-fold increase in mesenchymal stem cells. The marrow ablation injury mobilized all three cell types to the PB over time. Administration of AMD3100 led to a 60% increase in bone regeneration at Day 21. CONCLUSIONS: A single injection of a CXCR4 antagonist lead to stem cell mobilization and enhanced bone volume in the mouse marrow ablation model of intramembranous bone regeneration.
BACKGROUND: Stem cell mobilization, which is defined as the forced egress of stem cells from the bone marrow to the peripheral blood (PB) using chemokine receptor agonists, is an emerging concept for enhancing tissue regeneration. However, the effect of stem cell mobilization by a single injection of the C-X-C chemokine receptor type 4 (CXCR4) antagonist AMD3100 on intramembranous bone regeneration is unclear. QUESTIONS/PURPOSES: We therefore asked: Does AMD3100 mobilize adult stem cells in C57BL/6 mice? Are stem cells mobilized to the PB after marrow ablation? And does AMD3100 enhance bone regeneration? METHODS: Female C57BL/6 mice underwent femoral marrow ablation surgery alone (n = 25), systemic injection of AMD3100 alone (n = 15), or surgery plus AMD3100 (n = 57). We used colony-forming unit assays, flow cytometry, and micro-CT to investigate mobilization of mesenchymal stem cells, endothelial progenitor cells, and hematopoietic stem cells to the PB and bone regeneration. RESULTS: AMD3100 induced mobilization of stem cells to the PB, resulting in a 40-fold increase in mesenchymal stem cells. The marrow ablation injury mobilized all three cell types to the PB over time. Administration of AMD3100 led to a 60% increase in bone regeneration at Day 21. CONCLUSIONS: A single injection of a CXCR4 antagonist lead to stem cell mobilization and enhanced bone volume in the mouse marrow ablation model of intramembranous bone regeneration.
Authors: Simon C Pitchford; Rebecca C Furze; Carla P Jones; Antje M Wengner; Sara M Rankin Journal: Cell Stem Cell Date: 2009-01-09 Impact factor: 24.633
Authors: Elise F Morgan; Zachary D Mason; Karen B Chien; Anthony J Pfeiffer; George L Barnes; Thomas A Einhorn; Louis C Gerstenfeld Journal: Bone Date: 2008-10-25 Impact factor: 4.398
Authors: Wojciech Wojakowski; Michał Tendera; Magda Kucia; Ewa Zuba-Surma; Edyta Paczkowska; Joanna Ciosek; Maciej Hałasa; Marek Król; Maciej Kazmierski; Paweł Buszman; Andrzej Ochała; Janina Ratajczak; Bogusław Machaliński; Mariusz Z Ratajczak Journal: J Am Coll Cardiol Date: 2009-01-06 Impact factor: 24.094
Authors: Eduardo K Moioli; Paul A Clark; Mo Chen; James E Dennis; Helaman P Erickson; Stanton L Gerson; Jeremy J Mao Journal: PLoS One Date: 2008-12-15 Impact factor: 3.240
Authors: Chrisoula A Toupadakis; Jennifer L Granick; Myrrh Sagy; Alice Wong; Ehssan Ghassemi; Dai-Jung Chung; Dori L Borjesson; Clare E Yellowley Journal: Cytotherapy Date: 2013-07-03 Impact factor: 5.414
Authors: Timothy J Myers; Lara Longobardi; Helen Willcockson; Joseph D Temple; Lidia Tagliafierro; Ping Ye; Tieshi Li; Alessandra Esposito; Billie M Moats-Staats; Anna Spagnoli Journal: J Bone Miner Res Date: 2015-06-15 Impact factor: 6.741